«Wallerian Degeneration

Below is an extended Wallerian Degeneration patents listing. Click here to return to the Wallerian Degeneration main in depth entry.

Patents :
US Patent No.	Title
6399746	Structure, production and use of heregulin 2 ligands
6673832	Methods for identifying compounds for treating pain
6692444	Methods for the assessment of neuromuscular function by F-wave latency
6706764	Use of creatine or creatine analogs for the treatment of diseases of the nervous system
6825333	EGFH2 genes and gene products
6844314	Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
6845342	Determination of an empirical statistical distribution of the diffusion tensor in MRI
6870029	Method of diagnosing and treating gliomas
6896870	Diagnostic probes and therapeutics targeting uPA and uPAR
6903188	Neurogenic compositions and methods
6937904	System and method for providing recovery from muscle denervation
6667156	Diagnosis and treatment of neuroectodermal tumors
6649589	Use of certain drugs for treating nerve root injury
6635250	Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
6419934	TNF modulators for treating neurological disorders associated with viral infection
6419944	Cytokine antagonists for the treatment of localized disorders
6429187	Method of diagnosing and treating gliomas
6436129	Method and apparatus for stimulating nerve regeneration
6463315	Analysis of cerebral white matter for prognosis and diagnosis of neurological disorders
6501003	Transgentic mouse expressing green fluorescent protein in glial cells
6506727	Nerve regeneration
6537549	Cytokine antagonists for the treatment of localized disorders
6569423	Methods of inducing nervous tissue regeneration
6602851	SMDF and GGF neuregulin splice variant isoforms and uses thereof
6953842	Antibodies to heregulin 2
6972168	Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture
7285573	Use of creatine or creatine analogs for the treatment of diseases of the nervous system
7297099	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7300915	Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
7319107	1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
7333857	Treatment of pain
7335636	SPRR1A and axonal regeneration
7344555	Light promotes regeneration and functional recovery after spinal cord injury
7372267	Method and apparatus for generation of magnetization transfer contrast in steady state free precession magnetic resonance imaging
7375123	1,2,4-thiadiazole derivatives as melanocortin receptor modulators
7392140	Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
7276587	Antibodies to EGFH2 polypeptides
7250046	Treatment of lower extremity pain
7238659	Reducing axon degeneration with proteasome inhibitors
6989271	Schwann cells originating in myeloid interstitial cells
7012063	Reducing axon degeneration with proteasome inhibitors
7049331	1,2,4-thiadiazole derivatives as melanocortin receptor modulators
7098187	Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
7119069	Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
7189746	Methods for promoting wound healing
7198899	Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
7201896	IL6RIL6 chimera for the treatment of neurodegenerative diseases
7217687	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7226908	Use of VEGF and homologues to treat neuron disorders
7402319	Cell-free tissue replacement for tissue engineering

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.